USANA Reports Q3 2026 Results with Declining Net Sales and Adjusted EBITDA
USANA Health, Inc. reported third-quarter 2026 net sales of $206 million, a 4% year-over-year decline primarily driven by weakness in the Core Nutritional and Rise Wellness segments. The company's adjusted EBITDA fell 13% to $12.1 million compared to the previous year. A significant factor impacting results was an 8% year-over-year decrease in active customers within the Core Nutritional segment. Despite these headwinds, USANA saw strong growth in its Hiya brand, which achieved a 12% sequential increase in net sales and nearly doubled its retail performance through Target and Amazon. The company also reported improved liquidity with $179 million in cash and zero debt. However, management lowered full-year adjusted EBITDA guidance to $77 million from an earlier outlook of $80.5 million, citing marketing investments for customer acquisition and lumpy retail orders.
Tickers: $USNA
Topics: adjusted EBITDA financial guidance net sales subscriber growth